Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice [OMB Number 1117-0013]
 AGENCY: Drug Enforcement Administration, Department of Justice.
 ACTION: 60-Day notice.
 SUMMARY: The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
 DATES: Comments are encouraged and will be accepted for 60 days until November 13, 2023.
 FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Scott A. Brinks, Regulatory Drafting and Policy Support Section, Drug Enforcement Administration; Mailing Address: 8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 362-3261, Email: 
                        *scott.a.brinks@dea.gov.*


SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, 
                    *e.g.,*
                     permitting electronic submission of responses. *Abstract:*
                     Section 1002 of the Controlled Substances Import and Export Act (CSIEA) (21 U.S.C. 952) and Title 21, Code of Federal Regulations 21 CFR, sections 1312.11, 1312.12 and 1312.13 requires any person who desires to import controlled substances listed in schedules I or II, any narcotic substance listed in schedules III or IV, or any non-narcotic substance in schedule III which the Administrator has specifically designated by regulation in section 1312.30, or any nonnarcotic 
                    ( print page 62398)
                    substance in schedule IV or V which is also listed in schedule I or II of the Convention on Psychotropic Substances, must have an import permit. To obtain the permit to import controlled substances for domestic and or scientific purposes, an application for the permit must be made to the DEA, on DEA Form 357. Overview of This Information Collection 1. 
                    *Type of Information Collection:*
                     Extension of a previously approved collection. 2. 
                    *The Title of the Form/Collection:*
                     Application for Permit to Import Controlled Substances for Domestic and/or Scientific Purposes. 3. 
                    *The agency form number, if any, and the applicable component of the Department sponsoring the collection:*
                     DEA Form 357. The applicable component within the Department of Justice is the Drug Enforcement Administration, Office of Diversion Control. 4. 
                    *Affected public who will be asked or required to respond, as well as the obligation to respond:*
                     Affected Public: Private Sector—businesses or other for-profit institutions. The obligation to respond is mandatory per 21 CFR, sections 1312.11, 1312.12 and 1312.13. 5. 
                    *An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:*
                     The DEA estimates that 124 registrants participate in this information collection. The time per response is 21 minutes to complete the DEA-357 (paper) and 15 minutes to complete DEA-357 (online). 6. 
                    *An estimate of the total annual burden (in hours) associated with the collection:*
                     DEA estimates that this collection takes 264.35 annual burden hours. 7. 
                    *An estimate of the total annual cost burden associated with the collection, if applicable:*
                     $0. Total Burden Hours
Activity
Number of
                             respondents
Frequency
Total annual
                             responses
Time per
                             response 
                             (min.)
Total annual
                             burden 
                             (hours)DEA Form: 357 (online)
124
9
958
15
266DEA Form: 357 (paper)


71
21
19Unduplicated Totals
124

1,081
0.26
264.35
 *If additional information is required contact:*
                     Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 4W-218, Washington, DC. Dated: September 5, 2023. Darwin Arceo, Department Clearance Officer for PRA, U.S. Department of Justice.


[FR Doc. 2023-19536 Filed 9-8-23; 8:45 am] BILLING CODE 4410-09-P